← Evidence map

ArticleTherapeutic advances in gastroenterology2019

An expansion study of genotype-driven weekly irinotecan and capecitabine in combination with neoadjuvant radiotherapy for locally advanced rectal cancer with UGT1A1 *1*1 genotype.

Yun Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2019
2020
2021
2022
2023
2024
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 31217818